Evidence map›Paper›PMID 33318011›Full record

ArticleAntimicrobial agents and chemotherapy2021

Burkholderia ubonensis High-Level Tetracycline Resistance Is Due to Efflux Pump Synergy Involving a Novel TetA(64) Resistance Determinant.

Nawarat Somprasong, Carina M Hall, Jessica R Webb, Jason W Sahl, David M Wagner, Paul Keim, Bart J Currie, Herbert P Schweizer

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Functional analysis ofMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Nawarat SomprasongDepartment of Molecular Genetics & Microbiology, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Carina M HallThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
Jessica R WebbGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.ORCID 0000-0002-6332-039X
Jason W SahlThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
David M WagnerThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
Paul KeimThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.ORCID 0000-0003-0089-5820
Bart J CurrieGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Herbert P SchweizerDepartment of Molecular Genetics & Microbiology, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA Herbert.Schweizer@nau.edu.ORCID 0000-0002-8847-335X
Northern Arizona University · USCharles Darwin University · AUUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkholderia cepacia complexTetracyclineAnti-Bacterial AgentsBurkholderiaHumansTetracycline ResistanceAnti-Bacterial AgentsTetracyclineBurkholderiaefflux pumpresistancesynergytetA(64)tetracycline

Identifiers

PMID33318011
PMCPMC8092502
OpenAlexW3111251855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.